S. Choi

发表

Genetic changes during leukemic transformation to secondary acute myeloid leukemia from myeloproliferative neoplasms.

Zhaolei Zhang, Je-Jung Lee, Hyeoung-Joon Kim, 2022, Leukemia research.

CLINICAL Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy

Zhaolei Zhang, J. Lipton, Hyeoung-Joon Kim, 2016 .

Hydroxymethylcytosine correlates with epigenetic regulatory mutations , but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemia

C. Jung, Je-Jung Lee, Hyeoung-Joon Kim, 2017 .

Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant

M. Minden, C. Jung, Je-Jung Lee, 2015, Annals of Hematology.

Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia

Zhaolei Zhang, C. Jung, Je-Jung Lee, 2022, Bone Marrow Transplantation.

Exome sequencing reveals DNMT3A and ASXL1 variants associate with progression of chronic myeloid leukemia after tyrosine kinase inhibitor therapy.

Marc S. Tyndel, Zhaolei Zhang, J. Lipton, 2017, Leukemia research.

DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation.

Jong-Ho Won, Sang Kyun Sohn, Sung-Hoon Jung, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy.

Marc S. Tyndel, Zhaolei Zhang, J. Lipton, 2017, Blood.

Next-generation sequencing-based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse.

Marc S. Tyndel, Zhaolei Zhang, Y. Lee, 2018, Blood.

Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing

Zhaolei Zhang, Je-Jung Lee, Hyeoung-Joon Kim, 2020, Bone Marrow Transplantation.

Remission clone in acute myeloid leukemia shows growth advantage after chemotherapy but is distinct from leukemic clone.

Zhaolei Zhang, S. Ogawa, Kenichi Yoshida, 2019, Experimental hematology.

5-Hydroxymethylcytosine correlates with epigenetic regulatory mutations, but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemia

M. Minden, C. Jung, Je-Jung Lee, 2016, Oncotarget.

Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AML

C. Jung, Je-Jung Lee, Hyeoung-Joon Kim, 2016, Annals of Hematology.

The prognostic impact of reduced variant burden in elderly patients with acute myeloid leukemia treated with decitabine

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2023, The Korean journal of internal medicine.

RNA sequencing as an alternative tool for detecting measurable residual disease in core-binding factor acute myeloid leukemia

Marc S. Tyndel, Zhaolei Zhang, J. Cheong, 2020, Scientific Reports.

LAG-3xPD-L1 bispecific antibody potentiates antitumor responses of T cells through dendritic cell activation

S. Oh, H. Song, Yoon Park, 2022, Molecular therapy : the journal of the American Society of Gene Therapy.

The clonal origins of leukemic progression of myelodysplasia

S. Y. Kim, Marc S. Tyndel, Zhaolei Zhang, 2016, Leukemia.

Assessment of a new genomic classification system in acute myeloid leukemia with a normal karyotype

Zhaolei Zhang, C. Jung, Y. Lee, 2017, Oncotarget.